Impact of Antibiotic Choice at the Time of Sacral Neuromodulation Implantation on Rates of Surgical Site Infection
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.25595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Hope H Bauer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urogynecology, Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Surgical Wound Infection, Anti-Bacterial Agents, Antibiotic Prophylaxis. Die Arbeit nennt 23 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Purpose
To evaluate the efficacy of specific antibiotic regimens in preventing infection following sacral neuromodulation. Materials and Methods This is a retrospective cohort study utilizing the Premier Healthcare Database. Patients who underwent sacral neuromodulation placement between January 2016 and March 2020. The patients were grouped by those who received dual antibiotic therapy per 2019 AUA guidelines (Gram positive + broad Gram negative coverage), first‐ or second‐generation cephalosporins or any other regimen. Comparison between groups was performed using Kruskal–Wallis and χ 2 tests for continuous and categorical variables, respectively. Inverse probability of treatment weighted (IPTW) analysis was used to estimate the average treatment effect of AUA guidelines regimens versus the use the first‐ or second‐generation cephalosporins alone.
Results
The sample included 14 179 patients, with 2211 patients receiving prophylaxis that followed the AUA guideline recommendations. There was no significant difference in surgical site infection rates within 3 months ( p = 0.28) or within 12 months ( p = 0.53) between the groups. On IPTW, the probability of an infection at 3 months was lower with the AUA guideline regimens compared to those who received first‐ or second‐generation cephalosporins alone, but this difference was not statistically significant (OR = 0.73, 95% CI: [0.43, 1.24]).
Conclusions
In the absence of allergies to cephalosporins or penicillin, first‐ or second‐generation cephalosporins alone may be a sufficient preoperative antibiotic regimen for prevention of infection at the time of sacral neuromodulation. Trial Registration Not applicable due to being a database study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urogynecology, Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Bauer, H. H., Johnston, P. S., Rhodes, S. P., Hijaz, A. K., & Sheyn, D. (2025). Impact of Antibiotic Choice at the Time of Sacral Neuromodulation Implantation on Rates of Surgical Site Infection. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25595
Vancouver
Bauer HH, Johnston PS, Rhodes SP, Hijaz AK, Sheyn D. Impact of Antibiotic Choice at the Time of Sacral Neuromodulation Implantation on Rates of Surgical Site Infection. Neurourology and Urodynamics. 2025. doi:10.1002/nau.25595
BibTeX
@article{Bauer2025,
author = {Bauer, Hope H and Johnston, Peyton S and Rhodes, Stephen P and Hijaz, Adonis K and Sheyn, David},
title = {Impact of Antibiotic Choice at the Time of Sacral Neuromodulation Implantation on Rates of Surgical Site Infection},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.25595}
}
EUVIMED